HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Kiss Selected Research

ophiobolin A

3/2017Ophiobolin A, a sesterpenoid fungal phytotoxin, displays different mechanisms of cell death in mammalian cells depending upon the cancer cell origin.
10/2015Fungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure-activity relationship and unique pyrrolylation of primary amines.
10/2014Incorporation of ophiobolin a into novel chemoembolization particles for cancer cell treatment.
8/2013Ophiobolin A, a sesterterpenoid fungal phytotoxin, displays higher in vitro growth-inhibitory effects in mammalian than in plant cells and displays in vivo antitumor activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert Kiss Research Topics

Disease

155Neoplasms (Cancer)
01/2019 - 07/2002
48Glioblastoma (Glioblastoma Multiforme)
07/2018 - 07/2002
47Glioma (Gliomas)
07/2018 - 08/2002
27Melanoma (Melanoma, Malignant)
06/2017 - 10/2005
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2015 - 02/2006
8Lung Neoplasms (Lung Cancer)
04/2015 - 01/2005
8Prostatic Neoplasms (Prostate Cancer)
06/2011 - 03/2006
7Neoplasm Metastasis (Metastasis)
03/2013 - 09/2002
6Brain Neoplasms (Brain Tumor)
03/2013 - 01/2006
5Oligodendroglioma
04/2015 - 08/2002
5Carcinoma (Carcinomatosis)
05/2011 - 04/2003
4Breast Neoplasms (Breast Cancer)
04/2015 - 06/2002
4Colonic Neoplasms (Colon Cancer)
04/2015 - 06/2003
4Hypoxia (Hypoxemia)
03/2013 - 05/2008
4Carcinogenesis
01/2011 - 01/2005
4Adenocarcinoma
08/2007 - 06/2002
4Nasal Polyps (Nasal Polyp)
07/2004 - 02/2002
3Astrocytoma (Pilocytic Astrocytoma)
05/2011 - 07/2002
3Squamous Cell Carcinoma of Head and Neck
01/2008 - 07/2006
3Gliosarcoma
04/2005 - 09/2002
3Colorectal Neoplasms (Colorectal Cancer)
08/2004 - 01/2003
2Head and Neck Neoplasms (Head and Neck Cancer)
09/2016 - 03/2015
2Kidney Neoplasms (Kidney Cancer)
10/2015 - 05/2006

Drug/Important Bio-Agent (IBA)

31Pharmaceutical PreparationsIBA
01/2017 - 09/2005
27Galectin 1 (LGALS1)IBA
01/2017 - 02/2002
24Temozolomide (Temodar)FDA LinkGeneric
01/2017 - 08/2002
22Cytostatic AgentsIBA
02/2018 - 04/2003
20Proteins (Proteins, Gene)FDA Link
06/2017 - 08/2002
17Galectins (Galectin)IBA
04/2016 - 09/2002
16Biological ProductsIBA
01/2019 - 07/2002
15LigandsIBA
03/2013 - 06/2003
13Adenosine Triphosphatases (ATPase)IBA
06/2013 - 09/2007
12Antineoplastic Agents (Antineoplastics)IBA
10/2017 - 05/2008
11AlkaloidsIBA
02/2018 - 10/2004
10CardenolidesIBA
06/2013 - 02/2006
10Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA
03/2013 - 05/2006
9Galectin 3 (LGALS3)IBA
01/2010 - 01/2003
71-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
04/2016 - 01/2003
7Cardiac GlycosidesIBA
04/2013 - 09/2007
6DNA (Deoxyribonucleic Acid)IBA
06/2017 - 04/2005
6Small Interfering RNA (siRNA)IBA
04/2016 - 10/2007
6Ouabain (G Strophanthin)IBA
06/2013 - 02/2006
6Messenger RNA (mRNA)IBA
09/2012 - 09/2005
6GastrinsIBA
10/2005 - 07/2002
5Phosphotransferases (Kinase)IBA
04/2013 - 06/2010
5narciclasineIBA
03/2013 - 09/2007
5UNBS 1450IBA
09/2009 - 02/2006
5Biomarkers (Surrogate Marker)IBA
07/2006 - 07/2002
4Harmine (Telepathine)IBA
06/2017 - 07/2012
4ophiobolin AIBA
03/2017 - 08/2013
4Carrier Proteins (Binding Protein)IBA
02/2014 - 07/2002
4lycorineIBA
02/2014 - 10/2009
4hellebrinIBA
06/2013 - 04/2010
4Adenosine Triphosphate (ATP)IBA
03/2013 - 01/2008
4Cisplatin (Platino)FDA LinkGeneric
05/2011 - 03/2006
4IntegrinsIBA
04/2011 - 04/2005
4Irinotecan (Camptosar)FDA LinkGeneric
05/2007 - 10/2004
4LectinsIBA
07/2006 - 01/2003
3polygodialIBA
07/2018 - 10/2015
3Paclitaxel (Taxol)FDA LinkGeneric
04/2015 - 02/2005
3AcidsIBA
03/2015 - 10/2011
3Polysaccharides (Glycans)IBA
02/2014 - 08/2004
3ChemokinesIBA
05/2011 - 06/2008
3RNA (Ribonucleic Acid)IBA
11/2010 - 01/2003
3NaphthalimidesIBA
01/2009 - 08/2007
3Taxoids (Taxanes)IBA
06/2008 - 10/2004
3SelectinsIBA
05/2006 - 12/2002
3Cholecystokinin B ReceptorIBA
10/2005 - 01/2003
3S100 Proteins (S 100 Protein)IBA
11/2004 - 07/2002
3Budesonide (Pulmicort)FDA LinkGeneric
07/2004 - 02/2002
3EpitopesIBA
06/2003 - 12/2002
2MicroRNAs (MicroRNA)IBA
07/2018 - 02/2014
2Ion Channels (Ion Channel)IBA
07/2018 - 01/2012
2Histones (Histone)IBA
02/2018 - 01/2017
2Sirtuin 1IBA
02/2018 - 01/2017
2TubulinIBA
02/2018 - 09/2013
2norharmanIBA
06/2017 - 06/2017
2CaspasesIBA
03/2017 - 01/2010
2crinineIBA
09/2016 - 05/2012
2Amaryllidaceae AlkaloidsIBA
09/2016 - 07/2010
2SuspensionsIBA
04/2016 - 03/2010
2SteroidsIBA
03/2016 - 03/2006
2lapacholIBA
03/2016 - 01/2014
2SesquiterpenesIBA
12/2015 - 10/2015
2AminesIBA
10/2015 - 10/2015
2PlatinumIBA
12/2014 - 09/2010
2isostrychnopentamineIBA
12/2013 - 04/2010
2CXC ChemokinesIBA
12/2013 - 05/2011
2Dihydrotachysterol (AT 10)IBA
08/2013 - 06/2002
2hellebrigeninIBA
06/2013 - 04/2013
2BufanolidesIBA
06/2013 - 04/2013
2Cytotoxins (Cytolysins)IBA
06/2013 - 05/2007
2DiterpenesIBA
04/2013 - 10/2011
2PolyphenolsIBA
01/2013 - 07/2012
2QuercetinIBA
01/2013 - 03/2011
2Etoposide (VP 16)FDA LinkGeneric
11/2012 - 06/2002

Therapy/Procedure

22Therapeutics
07/2018 - 08/2002
22Drug Therapy (Chemotherapy)
07/2018 - 08/2002
10Radiotherapy
04/2013 - 04/2006
6Immunotherapy
01/2017 - 09/2007